Exchange: NYSE·Updated 07:56 PM EDT
News
all
press releases
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Penumbra, Inc. Reports Second Quarter 2026 Financial Results Penumbra, Inc. Reports Second Quarter 2026 Financial Results PR Newswire ALAMEDA, Calif., July 30, 2026 ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leadingthrombectomy company, today reported...
PR Newswire
More News
BSX Q2 Earnings Call Highlights WATCHMAN and EP Pressure
BSX faces WATCHMAN and EP pressures as management cuts outlook while highlighting cost savings and new product catalysts for future growth.
Zacks
Boston Scientific Cuts Forecast on Product Slowdown and Competition
Boston Scientific beat second-quarter estimates but lowered its 2026 sales and earnings outlook as restructuring costs weighed on guidance.read more...
Benzinga
Boston Scientific (BSX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
Boston Scientific Q2 Earnings & Revenues Top Estimates, Stock Climbs
BSX beats Q2 earnings and revenue estimates as cardiovascular growth, strong APAC and LACA sales, and margin expansion lift shares in pre-market.
Zacks
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
Boston Scientific (BSX) delivered earnings and revenue surprises of +3.61% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Boston Scientific announces results for second quarter 2026
Boston Scientific announces results for second quarter 2026 Boston Scientific announces results for second quarter 2026 PR Newswire MARLBOROUGH, Mass., July 29, 2026 MARLBOROUGH, Mass., July 29, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion...
PR Newswire
Boston Scientific Q2 26 Earnings Conference Call At 8:00 AM ET
(RTTNews) - Boston Scientific Corp (BSX) will host a conference call at 8:00 AM ET on July 29, 2026, to discuss Q2 26 earnings results...
Nasdaq News: Markets
J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?
J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.
Zacks
Here's How Much $100 Invested In Boston Scientific 15 Years Ago Would Be Worth Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.23% on an annualized basis producing an average annual return of 13.77%. Currently, Boston Scientific has a market capitalization ofread more...
Benzinga
<
1
2
>

Advertisement|Remove ads.